ENDONOVO THERAPEUTICS, INC. (ENDV) Total liabilities 2011–2022
ENDONOVO THERAPEUTICS, INC. (ENDV) total liabilities at each fiscal year-end, per SEC filings.
$33.5MFY2022 · since FY2011: $1.4M → $33.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $33.5M | +88.2% |
| FY2021 | $17.8M | +4.7% |
| FY2020 | $17.0M | -28.6% |
| FY2019 | $23.8M | +52.1% |
| FY2018 | $15.6M | — |
| FY2015 | $9.7M | +104.4% |
| FY2014 | $4.7M | +12.7% |
| FY2013 | $4.2M | +114.7% |
| FY2012 | $2.0M | +36.0% |
| FY2011 | $1.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice